Free Trial
CVE:SBM

Sirona Biochem (SBM) Stock Price, News & Analysis

Sirona Biochem logo
C$0.08 +0.01 (+15.38%)
(As of 10:01 AM ET)

About Sirona Biochem Stock (CVE:SBM)

Key Stats

Today's Range
C$0.08
C$0.08
50-Day Range
C$0.05
C$0.09
52-Week Range
C$0.02
C$0.12
Volume
25,002 shs
Average Volume
82,484 shs
Market Capitalization
C$19.26 million
P/E Ratio
N/A
Dividend Yield
1.50%
Price Target
N/A
Consensus Rating
N/A

Company Overview

Sirona Biochem Corp., a cosmetic ingredient and drug discovery company, develops and sells cosmetic and pharmaceutical active ingredients in Canada and France. Its programs include cosmetic skin lightener and diabetes drug; and other projects comprise the development of an anti-aging/cell protection library, novel anti-wrinkle compound, and anti-viral program. The company was formerly known as High Rider Capital Inc. and changed its name to Sirona Biochem Corp. in May 2009. Sirona Biochem Corp. was incorporated in 2006 and is headquartered in Vancouver, Canada.

Receive SBM Stock News and Ratings via Email

Sign-up to receive the latest news and ratings for Sirona Biochem and its competitors with MarketBeat's FREE daily newsletter.

SBM Stock News Headlines

Sirona Biochem Corp (SBM)
2025 AI Stock Picks: 2 Hidden Gems Under $10/Share
The AI sector continues to make waves as we move into 2025, and now is a prime opportunity to get involved—without stretching your budget! We’ve just uncovered 2 promising AI stocks trading for under $10/share, and they’re positioned for impressive growth in the coming months.
See More Headlines

SBM Stock Analysis - Frequently Asked Questions

Sirona Biochem's stock was trading at C$0.12 at the start of the year. Since then, SBM stock has decreased by 37.5% and is now trading at C$0.08.
View the best growth stocks for 2024 here
.

Shares of SBM stock and other Canadian stocks can be purchased through an online brokerage account. Popular online brokerages with access to the Canadian stock market include BMO InvestorLine, CIBC Investor's Edge, Desjardins Online Brokerage, HSBC InvestDirect, Laurentian Bank Discount Brokerage, National Bank Direct Brokerage, Qtrade Investor, Questrade, RBC Direct Investing, Scotia iTrade, TD Direct Investing, and Virtual Brokers.
Compare Top Brokerages Here.

Based on aggregate information from My MarketBeat watchlists, some other companies that Sirona Biochem investors own include Allena Pharmaceuticals (ALNA), Ampliphi Biosciences (APHB), Apellis Pharmaceuticals (APLS), Athersys (ATHX), Iovance Biotherapeutics (IOVA), Neovasc (NVCN) and Sorrento Therapeutics (SRNE).

Industry, Sector and Symbol

Sector
Medical
Industry
Biotechnology
Sub-Industry
N/A
CIK
N/A
Fax
N/A
Employees
N/A
Year Founded
N/A

Profitability

Net Income
C$-2,670,000.00
Pretax Margin
N/A

Debt

Sales & Book Value

Annual Sales
C$683,768.00
Cash Flow
C$0.00 per share
Book Value
C($0.01) per share

Miscellaneous

Free Float
N/A
Market Cap
C$19.26 million
Optionable
Not Optionable
Beta
-0.03
2025 Gold Forecast: A Perfect Storm for Demand Cover

Unlock the timeless value of gold with our exclusive 2025 Gold Forecasting Report. Explore why gold remains the ultimate investment for safeguarding wealth against inflation, economic shifts, and global uncertainties. Whether you're planning for future generations or seeking a reliable asset in turbulent times, this report is your essential guide to making informed decisions.

Get This Free Report

This page (CVE:SBM) was last updated on 11/21/2024 by MarketBeat.com Staff
From Our Partners